Résumé
En pédiatrie, l’endobrachyœsophage est considéré comme une manifestation rare d’un reflux gastro-œsophagien pathologique obligatoirement chronique. Il semble que le traitement précoce et efficace du reflux gastro-œsophagien chez le jeune enfant ait diminué l’incidence de l’œsophagite sévère et par conséquent, l’endobrachyœsophage est devenu de plus en plus rare. Actuellement, les complications les plus sévères s’observent de plus souvent chez l’enfant en cas de problèmes neurologiques graves, vraisemblablement en raison de la difficulté d’identifier et de traiter efficacement ce groupe particulier de malades.
Dans la mesure où l’endobrachyœsophage constitue une complication d’un reflux gastro-œsophagien pathologique chronique, l’efficacité d’un traitement anti-reflux et anti-acide mériterait d’être comparée à celle du traitement chirurgical classique.
Summary
Barrett’s oesophagus in children is considered as a rare manifestation of a chronic gastro-oesophageal reflux pathology. The impression exists (although this has not been evaluated scientifically) that early and efficient anti-reflux treatment during infancy has decreased the incidence of severe oesophagitis in childhood, and that as a consequence the incidence of Barrett’s oesophagus has also decreased. Nowadays, severe complications, such as a stricture, of gastro-oesophageal reflux are almost restricted to severely neurologically impaired children, probably because reflux pathology is difficult to recognise and to treat efficiently in this particular patient group.
If one accepts the idea that Barrett’s oesophagus is a complication of a chronic gastro-oesophageal reflux pathology, the efficiency of new potent anti-reflux and anti-acid secretory drugs would merit to be evaluated compared to the classic surgical treatement.
Références
BORRIE J., GOLDWATER L. — Columnar cell-lined esophagus: assessment of etiology and treatment.J. Thorac Cardiovasc. Surg., 1976;71, 825–834.
BRAND D.L., YLVISAKER J.T., GELFAND M., POPE C.E. — Regression of columnar esophageal (Barrett’s) epithelium after anti-reflux surgery.N. Engl. Med. J., 1980,302, 844–848.
COOPER J.E., SPITZ L., WILKINS B.M. — Barrett’s esophagus in children: a histologic and histochemical study of 11 cases.J. Pediatr. Surg., 1987,22, 191–196.
DAHMS B.B., ROTHSTEIN F.C. — Barrett’s esophagus in children: a consequence of chronic gastroesophageal reflux.Gastroenterology, 1984,86 : 318–323.
ENDO M., KOBAYASHI S., KOZU T., TAKEMOTO T., NAKAYAMA K. — A case of Barrett epithelisation followed up for five years.Endoscopy, 1974,6, 48–51.
EVERHART C.W., HOLZAPPLE P.G., HUMPHRIES T.J. — Barrett’s esophagus: inherited epithelium or inherited reflux ?J. Clin. Gastroenterol, 1983,5, 357–360.
HASSALL E., WEINSTEIN W.M., AMENT M. — Barrett’s esophagus in childhood.Gastroenterology, 1985,89, 1331–1337.
HOEFFEL J.C., NIHOUL-FEKETE C., SCHMITT M. — Esophageal adenocarcinoma after gastroesophageal reflux in children.J. Pediatr., 1989,115, 259–261.
PEETERS S., VANDENPLAS Y. — Sex ratio and gastroesophageal reflux in infancy.J. Pediatr. Gastro. Nutr., 1991,13, 314.
PHILLIPS R.W., WONG R.K.H. — Barrett’s esophagus. Natural history, incidence, etiology, and complications.Gastroenterol. Clin. N. Am., 1991,20, 791–816.
SACRE L., VANDENPLAS Y. — Gastroesophageal reflux associated with respiratory abnormalities during sleep.J. Pediatr. Gastro. Nutr., 1989,9, 28–33.
VANDENPLAS Y. — Oesophageal pH monitoring for gastro-oesophageal reflux in infants and children. Ed. J. Wiley & Sons. London, 1992.
WIENBECK M., BARNERT J. — Epidemiology of reflux disease and reflux esophagitis.Scand. J. Gastroenterol., 1989,Suppl. 156, 7–13.
Author information
Authors and Affiliations
About this article
Cite this article
Vandenplas, Y. Les indications particulières de la chirurgie de l’endobrachyœsophage chez l’enfant. Acta Endosc 23, 125–128 (1993). https://doi.org/10.1007/BF02968623
Issue Date:
DOI: https://doi.org/10.1007/BF02968623